Market revenue in 2023 | USD 4.2 million |
Market revenue in 2030 | USD 10.3 million |
Growth rate | 13.5% (CAGR from 2023 to 2030) |
Largest segment | Neurology |
Fastest growing segment | Orthopedic |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Dental, Orthopedic, Neurology |
Key market players worldwide | GlaxoSmithKline, Hewlett Packard Enterprise Co, Merck KGaA, AstraZeneca PLC, Aprecia Pharmaceuticals, Extend Biosciences, BioDuro, Affini-T Therapeutics, Osmotica Pharmaceutical, FabRx, Cycle Pharmaceuticals |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to 3d printed drugs market will help companies and investors design strategic landscapes.
Neurology was the largest segment with a revenue share of 50% in 2023. Horizon Databook has segmented the Canada 3d printed drugs market based on dental, orthopedic, neurology covering the revenue growth of each sub-segment from 2018 to 2030.
Canada's 3D printed drugs market is driven by its robust healthcare system and a keen focus on technological innovation. Furthermore, an increasing geriatric population prone to various diseases is anticipated to boost the demand for 3D printed drugs. For instance, according to a Statistics Canada report, in 2021, over 861,000 people aged 85 and older were living in the country.
3D printing technology offers a viable solution to tailor medications to meet the specific needs of the elderly considering factors such as their unique physiological and medical requirements. However, 3D printing technology in the pharmaceutical industry in Canada faces several challenges, including limited adoption due to high capital investment and uncertain Return On Investment (ROI).
Horizon Databook provides a detailed overview of country-level data and insights on the Canada 3d printed drugs market , including forecasts for subscribers. This country databook contains high-level insights into Canada 3d printed drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account